Payment overview · 2025
General Payments
$16.67
1 reported records · 1 companies
Healthcare provider profile · identity verified
Miteshkumar Patel
Allopathic & Osteopathic Physicians|Family Medicine · SAN FRANCISCO, CA · NPI 1003255910
Verified facts
What the public records show
CMS Open Payments records show Miteshkumar Patel received $16.67 in general payments during 2025 across 1 reported records.
PFIZER INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1019 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $16.67 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.67 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $16.67 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1019 | 89 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1795 | 194 |
| Amlodipine Besylate | Amlodipine Besylate | 1338 | 157 |
| Eliquis | Apixaban | 1019 | 89 |
| Pantoprazole Sodium | Pantoprazole Sodium | 921 | 112 |
| Gabapentin | Gabapentin | 697 | 83 |
| Tamsulosin Hcl | Tamsulosin Hcl | 629 | 78 |
| Losartan Potassium | Losartan Potassium | 623 | 77 |
| Levothyroxine Sodium | Levothyroxine Sodium | 514 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 446 | 61 |
| Furosemide | Furosemide | 404 | 66 |
| Donepezil Hcl | Donepezil Hcl | 396 | 47 |
| Metformin Hcl | Metformin Hcl | 371 | 48 |
| Metoprolol Tartrate | Metoprolol Tartrate | 360 | 46 |
| Famotidine | Famotidine | 327 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 261 | 35 |
| Finasteride | Finasteride | 255 | 40 |
| Lisinopril | Lisinopril | 247 | 32 |
| Carvedilol | Carvedilol | 231 | 34 |
| Omeprazole | Omeprazole | 221 | 36 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 216 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 215 | 31 |
| Allopurinol | Allopurinol | 202 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 201 | 42 |
| Latanoprost | Latanoprost | 199 | 43 |
| Levetiracetam | Levetiracetam | 174 | 26 |
| Memantine Hcl | Memantine Hcl | 174 | 14 |
| Simvastatin | Simvastatin | 172 | 22 |
| Xarelto | Rivaroxaban | 172 | 16 |
| Januvia | Sitagliptin Phosphate | 171 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 167 | 56 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 161 | 32 |
| Trazodone Hcl | Trazodone Hcl | 161 | 28 |
| Jardiance | Empagliflozin | 156 | 18 |
| Mirtazapine | Mirtazapine | 136 | 27 |
| Olanzapine | Olanzapine | 135 | 16 |
| Entresto | Sacubitril/Valsartan | 118 | 13 |
| Glipizide | Glipizide | 118 | 11 |
| Spironolactone | Spironolactone | 117 | 17 |
| Diltiazem Hcl | Diltiazem Hcl | 113 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 107 | 16 |
| Lidocaine | Lidocaine | 105 | 33 |
| Potassium Chloride | Potassium Chloride | 105 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 104 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 99 | 17 |
| Novolog Flexpen | Insulin Aspart | 98 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 97 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 95 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 95 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 91 | 19 |
| Lovastatin | Lovastatin | 91 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 91 | 26 |
| Metformin Hcl Er | Metformin Hcl | 90 | suppressed |
| Lansoprazole | Lansoprazole | 87 | 12 |
| Baclofen | Baclofen | 85 | 18 |
| Ezetimibe | Ezetimibe | 84 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 82 | 82 |
| Divalproex Sodium | Divalproex Sodium | 80 | 12 |
| Celecoxib | Celecoxib | 79 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 79 | 11 |
| Clonidine Hcl | Clonidine Hcl | 78 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 78 | 14 |
| Terazosin Hcl | Terazosin Hcl | 76 | suppressed |
| Prednisone | Prednisone | 75 | 37 |
| Amiodarone Hcl | Amiodarone Hcl | 74 | 12 |
| Sevelamer Carbonate | Sevelamer Carbonate | 68 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 67 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 66 | 12 |
| Bumetanide | Bumetanide | 65 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 61 | 31 |
| Ondansetron Odt | Ondansetron | 59 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 58 | suppressed |
| Tradjenta | Linagliptin | 55 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 54 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 54 | 11 |
| Brilinta | Ticagrelor | 53 | suppressed |
| Calcium Acetate | Calcium Acetate | 52 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 31 |
| Alendronate Sodium | Alendronate Sodium | 51 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 51 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 50 | 11 |
| Aripiprazole | Aripiprazole | 49 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 19 |
| Naproxen | Naproxen | 47 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 47 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 47 | 22 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 46 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 45 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 45 | suppressed |
| Clotrimazole | Clotrimazole | 42 | 14 |
| Timolol Maleate | Timolol Maleate | 42 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 17 |
| Heparin Sodium | Heparin Sodium,porcine | 40 | 16 |
| Buspirone Hcl | Buspirone Hcl | 39 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 39 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 39 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Nifedipine Er | Nifedipine | 38 | suppressed |
| Risperidone | Risperidone | 38 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 37 | suppressed |
| Digoxin | Digoxin | 37 | suppressed |
| Humalog | Insulin Lispro | 37 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 35 | 13 |
| Topiramate | Topiramate | 35 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 34 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 34 | suppressed |
| Mupirocin | Mupirocin | 34 | 17 |
| Valsartan | Valsartan | 34 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 32 | suppressed |
| Hydrocortisone | Hydrocortisone | 31 | 16 |
| Lactulose | Lactulose | 31 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 31 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 30 | suppressed |
| Atenolol | Atenolol | 29 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 29 | 16 |
| Nystop | Nystatin | 29 | 17 |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Xifaxan | Rifaximin | 29 | suppressed |
| Cephalexin | Cephalexin | 28 | 16 |
| Divalproex Sodium Er | Divalproex Sodium | 28 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 28 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Sucralfate | Sucralfate | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 24 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 24 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 20 |
| Doxepin Hcl | Doxepin Hcl | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Moxifloxacin Hcl | Moxifloxacin Hcl | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Invokana | Canagliflozin | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Enulose | Lactulose | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Ozempic | Semaglutide | 20 | suppressed |
| Tirosint | Levothyroxine Sodium | 20 | suppressed |
| Anastrozole | Anastrozole | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Haloperidol | Haloperidol | 19 | suppressed |
| Levemir Flexpen | Insulin Detemir | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Cyclosporine | Cyclosporine | 18 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 18 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 18 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 18 | 11 |
| Perphenazine | Perphenazine | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Febuxostat | Febuxostat | 17 | suppressed |
| Humulin R | Insulin Regular, Human | 17 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 12 |
| Propafenone Hcl | Propafenone Hcl | 17 | suppressed |
| Ursodiol | Ursodiol | 17 | suppressed |
| Insulin Lispro | Insulin Lispro | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 16 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| K-Phos Original | Potassium Phosphate,monobasic | 15 | suppressed |
| Levocarnitine | Levocarnitine | 15 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 15 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 15 | suppressed |
| Valproic Acid | Valproic Acid | 15 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Glucagon Emergency Kit | Glucagon | 13 | suppressed |
| Insulin Aspart | Insulin Aspart | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Minoxidil | Minoxidil | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Betoptic S | Betaxolol Hcl | 11 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 11 | suppressed |
| Voriconazole | Voriconazole | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.67 · 1 records | PFIZER INC. | PAXLOVID | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error